FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401967592> ?p ?o ?g. }

• W2401967592 endingPage "5984" @default.
• W2401967592 startingPage "5979" @default.
• W2401967592 abstract "To evaluate the dose-limiting toxicities (DLTs) and determine the maximum-tolerated dose (MTD) and recommended dose (RD) of combination chemotherapy with gemcitabine, cisplatin and S-1 which is an oral fluoropyrimidine pro-drug in patients with advanced biliary tract cancer.Patients with histologically or cytologically confirmed unresectable or recurrent biliary tract cancer were enrolled. The planned dose levels of gemcitabine (mg/m(2)), cisplatin (mg/m(2)), and S-1 (mg/m(2) per day) were as follows: level -1, 800/20/60; level 0, 800/25/60; level 1, 1000/25/60; and level 2, 1000/25/80. In each cycle, gemcitabine and cisplatin were administered intravenously on days 1 and 15, and S-1 was administered orally twice daily on days 1 to 7 and days 15 to 21, every 4 wk.Twelve patients were enrolled, and level 0 was chosen as the starting dose. None of the first three patients had DLTs at level 0, and the dose was escalated to level 1. One of six patients had DLTs (grade 4 febrile neutropenia, leucopenia, and neutropenia; grade 3 thrombocytopenia) at level 1. We then proceeded to level 2. None of three patients had DLTs during the first cycle. Although the MTD was not determined, level 2 was designated at the RD for a subsequent phase II study.The RD was defined as gemcitabine 1000 mg/m(2) (days 1, 15), cisplatin 25 mg/m(2) (days 1, 15), and S-1 80 mg/m(2) per day (days 1-7, 15-21), every 4 weeks. A phase II study is planned to evaluate the effectiveness of combination chemotherapy with gemcitabine, cisplatin, and S-1 in advanced biliary tract cancer." @default.
• W2401967592 created "2016-06-24" @default.
• W2401967592 creator A5011290113 @default.
• W2401967592 creator A5013128552 @default.
• W2401967592 creator A5024392136 @default.
• W2401967592 creator A5030012941 @default.
• W2401967592 creator A5045772874 @default.
• W2401967592 creator A5052802533 @default.
• W2401967592 creator A5068184724 @default.
• W2401967592 creator A5068425977 @default.
• W2401967592 creator A5073287396 @default.
• W2401967592 creator A5091495712 @default.
• W2401967592 date "2015-05-21" @default.
• W2401967592 modified "2023-10-17" @default.
• W2401967592 title "Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer" @default.
• W2401967592 cites W1499419719 @default.
• W2401967592 cites W1972107936 @default.
• W2401967592 cites W1983970003 @default.
• W2401967592 cites W1992836159 @default.
• W2401967592 cites W2019438357 @default.
• W2401967592 cites W2038787775 @default.
• W2401967592 cites W2054178056 @default.
• W2401967592 cites W2064792760 @default.
• W2401967592 cites W2082189234 @default.
• W2401967592 cites W2086007888 @default.
• W2401967592 cites W2086686513 @default.
• W2401967592 cites W2096934836 @default.
• W2401967592 cites W2115261608 @default.
• W2401967592 cites W2119534563 @default.
• W2401967592 cites W2133438879 @default.
• W2401967592 cites W2137991416 @default.
• W2401967592 cites W2144412903 @default.
• W2401967592 cites W2151253787 @default.
• W2401967592 cites W2171075804 @default.
• W2401967592 cites W2437968144 @default.
• W2401967592 doi "https://doi.org/10.3748/wjg.v21.i19.5979" @default.
• W2401967592 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4438033" @default.
• W2401967592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26019463" @default.
• W2401967592 hasPublicationYear "2015" @default.
• W2401967592 type Work @default.
• W2401967592 sameAs 2401967592 @default.
• W2401967592 citedByCount "5" @default.
• W2401967592 countsByYear W24019675922017 @default.
• W2401967592 countsByYear W24019675922019 @default.
• W2401967592 countsByYear W24019675922021 @default.
• W2401967592 countsByYear W24019675922023 @default.
• W2401967592 crossrefType "journal-article" @default.
• W2401967592 hasAuthorship W2401967592A5011290113 @default.
• W2401967592 hasAuthorship W2401967592A5013128552 @default.
• W2401967592 hasAuthorship W2401967592A5024392136 @default.
• W2401967592 hasAuthorship W2401967592A5030012941 @default.
• W2401967592 hasAuthorship W2401967592A5045772874 @default.
• W2401967592 hasAuthorship W2401967592A5052802533 @default.
• W2401967592 hasAuthorship W2401967592A5068184724 @default.
• W2401967592 hasAuthorship W2401967592A5068425977 @default.
• W2401967592 hasAuthorship W2401967592A5073287396 @default.
• W2401967592 hasAuthorship W2401967592A5091495712 @default.
• W2401967592 hasBestOaLocation W24019675921 @default.
• W2401967592 hasConcept C121608353 @default.
• W2401967592 hasConcept C126322002 @default.
• W2401967592 hasConcept C2775982439 @default.
• W2401967592 hasConcept C2776694085 @default.
• W2401967592 hasConcept C2777063308 @default.
• W2401967592 hasConcept C2777299880 @default.
• W2401967592 hasConcept C2777844706 @default.
• W2401967592 hasConcept C2778239845 @default.
• W2401967592 hasConcept C2778850193 @default.
• W2401967592 hasConcept C2780258809 @default.
• W2401967592 hasConcept C3017919176 @default.
• W2401967592 hasConcept C31760486 @default.
• W2401967592 hasConcept C71924100 @default.
• W2401967592 hasConcept C90924648 @default.
• W2401967592 hasConceptScore W2401967592C121608353 @default.
• W2401967592 hasConceptScore W2401967592C126322002 @default.
• W2401967592 hasConceptScore W2401967592C2775982439 @default.
• W2401967592 hasConceptScore W2401967592C2776694085 @default.
• W2401967592 hasConceptScore W2401967592C2777063308 @default.
• W2401967592 hasConceptScore W2401967592C2777299880 @default.
• W2401967592 hasConceptScore W2401967592C2777844706 @default.
• W2401967592 hasConceptScore W2401967592C2778239845 @default.
• W2401967592 hasConceptScore W2401967592C2778850193 @default.
• W2401967592 hasConceptScore W2401967592C2780258809 @default.
• W2401967592 hasConceptScore W2401967592C3017919176 @default.
• W2401967592 hasConceptScore W2401967592C31760486 @default.
• W2401967592 hasConceptScore W2401967592C71924100 @default.
• W2401967592 hasConceptScore W2401967592C90924648 @default.
• W2401967592 hasIssue "19" @default.
• W2401967592 hasLocation W24019675921 @default.
• W2401967592 hasLocation W24019675922 @default.
• W2401967592 hasLocation W24019675923 @default.
• W2401967592 hasLocation W24019675924 @default.
• W2401967592 hasOpenAccess W2401967592 @default.
• W2401967592 hasPrimaryLocation W24019675921 @default.
• W2401967592 hasRelatedWork W2006849884 @default.
• W2401967592 hasRelatedWork W2077501165 @default.
• W2401967592 hasRelatedWork W2534888322 @default.
• W2401967592 hasRelatedWork W2768466493 @default.
• W2401967592 hasRelatedWork W3008548200 @default.

• next